PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.00 - 0.01
0.00 - 0.02
1.30M / 496.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-100.00%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-100.00%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
100.00%
Positive EBIT growth while LBL.AX is negative. John Neff might see a substantial edge in operational management.
100.00%
Positive operating income growth while LBL.AX is negative. John Neff might view this as a competitive edge in operations.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Share reduction while LBL.AX is at 2.48%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Negative 10Y revenue/share CAGR while LBL.AX stands at 228.01%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-100.00%
Negative 5Y CAGR while LBL.AX stands at 46.12%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
No Data
No Data available this quarter, please select a different quarter.
100.00%
10Y OCF/share CAGR above 1.5x LBL.AX's 45.65%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
100.00%
5Y OCF/share CAGR above 1.5x LBL.AX's 30.04%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Negative 10Y net income/share CAGR while LBL.AX is at 196.67%. Joel Greenblatt sees a major red flag in long-term profit erosion.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-100.00%
We cut SG&A while LBL.AX invests at 28.87%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.